查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197869

氧化应激测定市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Oxidative Stress Assay Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

氧化应激检测市场预计在预测期内（2022 年至 2027 年）的复合年增长率为 9%。

在 COVID-19 期间，由于全球对研发活动的投资增加，预计氧化应激分析市场将会增长。 根据一篇题为“氧化应激和炎症过程对 SARS-CoV-2 发病机制的代谢影响”的论文。 根据 2021 年 5 月天然抗氧化剂的治疗潜力，氧化应激和炎症通过干扰多种信号通路在疾病进展和对治疗的反应中发挥重要作用。据说这是一个相互交织的过程。 由于确保病毒结合和进入宿主细胞的构象变化所需的独特条件，宿主细胞氧化还原状态是病毒进入的关键因素。 这些研究证明了氧化应激分析在发现 COVID-19 的进展方面有多么有用，并可能在未来几年推动市场增长。

生物製药和生物技术行业的快速增长以及慢性病的增加是预计将推动氧化应激分析市场增长的主要因素。 根据疾病控制与预防中心 (CDC) 2022 年 5 月更新，美国十分之六的成年人患有慢性病，十分之四的人患有两种或多种疾病。 如此高的慢性病患病率增加了对氧化应激检测的需求，因为慢性病会导致氧化剂和抗氧化水平失衡，从而提高结果的有效性和准确性。我是。

此外，为扩大氧化应激分析在各种疾病中的应用而进行的越来越多的研究也在推动市场增长。 例如，在 2021 年 9 月发表的文章“Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurpose Drug as an Anticancer Therapy”中，当浓度增加时，活性氧 (ROS) 反常地影响癌症的发展。据报导，中度高水平的 ROS 诱导肿瘤发生或支持癌细胞增殖，而高水平的 ROS 导致癌细胞死亡。 因此，活性氧可以被认为是癌症治疗的有吸引力的目标。 此外，据报导，使用活性氧的回收药物可能是克服当前癌症治疗挑战的有前途的方法之一。 此类研究和开发可能会导致新产品的开发和癌症诊断和治疗应用的扩展，从而可能在不久的将来推动市场增长。

因此，由于上述因素，市场有望在预测期内实现增长。 然而，设备的高成本和缺乏训练有素的人员来处理设备可能会阻碍市场增长。

氧化应激分析市场趋势

在氧化应激分析市场，製药和生物技术行业预计将占据主要市场份额。

按最终用户划分，製药和生物技术行业预计将占据最大份额。 COVID-19 的突然爆发增加了对氧化应激分析的需求，因为它们在製药和生物技术行业的研发中发挥着重要作用。 由于氧化应激分析广泛用于产品开发过程，预计製药和生物技术行业的研发投资激增将推动该领域的增长。 例如，根据经济发展与合作组织（OECD）2021年公布的数据，美国在医药和生物技术领域的研发投入强度跨过了3%的里程碑，而中国则从2.1%上升到去年 2.2%。据报导。 另据报导，欧洲的研发支出增长率较为温和，为 2.1%。

此外，监管机构的产品批准和新产品的发布也促进了这一细分市场的增长。 例如，2022年6月，AMSBIO将提供自由基（ROS和RNS）、非自由基活性衍生物（或氧化剂）、与抗氧化剂相关的抗体、生物标记物和检测试剂盒的范围扩大。

考虑到这些因素，由于在新疾病诊断的研发中采用了大量氧化应激分析产品，因此製药和生物技术行业预计将占据主要市场份额。

北美将占据很大的市场份额，预计在预测期内也会如此

该地区生物製药和生物技术公司的需求持续增长，预计将推动北美氧化应激分析市场的增长。 此外，越来越多地采用技术先进的设备和经验丰富的专业人员的出现预计将推动该地区的市场增长。 生物製药公司推出越来越多的新产品也促进了市场增长，因为氧化应激分析在生物製药生产中发挥着重要作用。

此外，美国在生物技术领域加大研发投资也对该地区氧化应激分析市场的增长做出了重大贡献。 例如，总部位于加州的安进公司在研发活动上投入巨资，2021 年、2020 年和 2019 年的研发支出分别为 48 亿美元、42 亿美元和 41 亿美元。

此外，市场进入者的战略举措也在推动市场增长。 例如，2021 年 7 月，Immuchrom GmbH 与 Ilex Life Sciences 就胃肠道生物标誌物检测在北美的商业化达成了合作协议。 Immuchrom 是一家德国公司，开发和製造 HPLC 应用、光度测定和免疫测定，专注于胃肠道疾病、心血管疾病、氧化应激、钙和骨代谢领域。 这些努力也推动了市场的增长。

因此，考虑到所有这些因素，预计北美将占据氧化应激市场的主要份额。

氧化应激检测市场的竞争者分析

氧化应激分析市场是分散的，由几个主要参与者组成。 从市场份额的角度来看，一些主要参与者目前主导着市场。 目前的市场垄断企业包括 Abcam Plc、AMSBIO、Biovision Inc、Cell Biolabs, Inc、Enzo Life Sciences, Inc、Merck KGaA、Immunochemistry Technologies、Promega Corporation、Qiagen、Thermo Fisher Scientific 等。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 生物製药和生物技术行业的快速增长
    • 增加研发投资
  • 市场製约因素
    • 设备成本高
    • 缺乏经验丰富的人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 医疗设备
    • 消耗品
    • 服务
  • 按测试类型
    • 间接测量法
    • 抗氧化能力测定
    • □分析
    • 活性氧测量方法
  • 按技术
    • □联免疫吸附试验 (ELISA)
    • 流式细胞术
    • 色谱法
    • 显微镜
    • 其他
  • 按疾病类型
    • 心血管疾病
    • 慢性阻塞性肺疾病 (COPD)
    • 癌症
  • 最终用户
    • 製药和生物技术公司
    • 学术研究所
    • 临床研究所
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • Abcam PLC
    • AMSBIO
    • Biovision Inc
    • Cell Biolabs, Inc
    • Enzo life sciences, Inc
    • Merck KGaA
    • ImmunoChemistry Technologies
    • Promega Corporation
    • Qiagen
    • Thermo fisher scientific

第7章 市场机会与今后动向

简介目录
Product Code: 90455

The Oxidative Stress Assay Market is projected to register a CAGR of 9% during the forecast period (2022-2027).

Amidst COVID-19, the oxidative stress assay market is expected to grow due to the increasing investment in research and development activities across the globe. According to the article titled "Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants" published in May 2021, oxidative stress and inflammation are intertwined processes that play a vital role in disease progression and response to therapy via interference with multiple signaling pathways. The redox status of a host cell is an important factor in viral entry due to the unique conditions required for the conformational changes that ensure the binding and entry of a virus into the host cell. Such studies demonstrate how oxidative stress assays can be useful in finding COVID-19 progression and may propel the growth of the market over the coming years.

The rapid growth in the biopharmaceutical and biotechnology industries and the increase in chronic disorders are among the major factors expected to drive the growth of the oxidative stress assay market. According to the Center for Disease Control and Prevention (CDC) May 2022 update, six in ten adults in the United States have a chronic disease, and four in ten adults have two or more. Such a high prevalence of chronic diseases increased the demand for oxidative stress assays owing to the increased efficacy and precision of the results as chronic disorders result in an imbalance in oxidant and antioxidant levels.

Additionally, the increasing research studies to widen the application of the oxidative stress assay in different diseases is also propelling the growth of the market. For instance, the article titled "Targeting Reactive Oxygen Species Capacity of Tumor Cells with Repurposed Drug as an Anticancer Therapy" published in September 2021 reported that as concentrations increased, Reactive Oxygen Species (ROS) paradoxically influenced cancer development, either triggering tumorigenesis or supporting the proliferation of cancer cells at moderate levels of ROS or causing cancer cell death at high levels of ROS. Thus, ROS can be considered an attractive target for the therapy of cancer. It also reported that the use of ROS-based repurposed drugs may be one of the promising ways to overcome current cancer treatment challenges. Such research studies could lead to the development of new products and increasing applications in cancer diagnostics and therapeutics and hence may drive the growth of the market in the near future.

Therefore, due to the aforesaid factors, the market is expected to project growth over the forecast period. However, the high cost of equipment and the lack of trained personnel to handle the equipment may hamper the market's growth.

Oxidative Stress Assay Market Trends

The Pharmaceutical and Biotechnology Industries Segment is Expected to Hold a Major Market Share in the Oxidative Stress Assay Market.

By end user, the pharmaceutical and biotechnology industries segment is anticipated to garner the largest share of the market. The sudden outbreak of COVID-19 has increased the demand for oxidative stress assays as these products play a major role in the research and development of the pharmaceutical and biotechnology industries. The surge in research and development investments in the pharmaceutical and biotechnology industries is expected to boost the segment's growth since oxidative stress assays are widely used in the product development process. For instance, the data published by the Organisation for Economic Development and Co-operation (OECD) in 2021 reported that research and development investment intensity in the pharmaceutical and biotechnology sectors in the United States surpassed the 3% milestone, while in China it was 2.1% to 2.2% from the past year. The report also stated that Europe experienced a more modest increase of 2.1 percent in research and development expenditure.

Additionally, the approval of products by the regulatory authorities and the launch of newer products are also contributing to the growth of the segment. For instance, in June 2022, AMSBIO expanded its range of antibodies, biomarkers, and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants), and antioxidants for researchers investigating the mechanism of oxidative stress.

Considering these factors, the pharmaceutical and biotechnology industry segment is expected to hold the major market share as they employ a significant number of oxidative stress assay products for the R&D of newer disease diagnoses.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

The ever-increasing demand from biopharma and biotechnology companies in this region is expected to drive the growth of the oxidative stress assay market in North America. Moreover, the increase in the adoption of technologically advanced equipment and the presence of more experienced professionals is expected to propel the market growth in this region. Also, the increasing launches of new products by biopharma companies is a contributing factor to the growth of the market as oxidative stress assays play a crucial role in biopharmaceutical production.

Additionally, an upsurge in investment in research and development in the biotechnology sector in the United States is a major contributing factor to the growth of the oxidative stress assay market in this region. For instance, California-based Amgen Inc. invested heavily in its research and development activities and its expenditure for research and development was USD 4.8 billion, USD 4.2 billion, and USD 4.1 billion for 2021, 2020, and 2019, respectively.

Additionally, the strategic initiatives taken by the market players are also propelling the growth of the market. For instance, in July 2021, ImmuchromGmbH signed a partnership agreement with Ilex Life Sciences for North American distribution of gastrointestinal biomarker assays. Immuchrom is a German developer and manufacturer of HPLC applications, photometric assays, and immunoassays, specializing in areas of gastrointestinal disease, the cardiovascular system, oxidative stress, and calcium and bone metabolism. Such initiatives are also boosting the growth of the market.

Thus, considering all these factors, North America is expected to hold a major share in the oxidative stress market.

Oxidative Stress Assay Market Competitor Analysis

The oxidative stress assay market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Abcam Plc, AMSBIO, Biovision Inc, Cell Biolabs, Inc, Enzo Life Sciences, Inc, Merck KGaA, Immunochemistry Technologies, Promega Corporation, Qiagen, Thermo Fisher Scientific, and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapid Growth in Biopharmaceutical and Biotechnology Industries
    • 4.2.2 Increasing Investment in the Research and Development
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Equipment
    • 4.3.2 Lack of Experienced Personnel
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.2 Consumables
    • 5.1.3 Services
  • 5.2 By Test Type
    • 5.2.1 Indirect assays
    • 5.2.2 Antioxidant capacity assays
    • 5.2.3 Enzyme based assays
    • 5.2.4 Reactive Oxygen species based assays
  • 5.3 By Technology
    • 5.3.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 5.3.2 Flow Cytometry
    • 5.3.3 Chromatography
    • 5.3.4 Microscopy
    • 5.3.5 Others
  • 5.4 By Disease Type
    • 5.4.1 Cardiovascular disease
    • 5.4.2 Chronic Obstructive pulmonary disease (COPD)
    • 5.4.3 Cancer
  • 5.5 By End User
    • 5.5.1 Pharmaceutical and Biotechnology Industries
    • 5.5.2 Academic Research institutes
    • 5.5.3 Clinical Research Organizations
  • 5.6 Geography
    • 5.6.1 North America
      • 5.6.1.1 United States
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
    • 5.6.2 Europe
      • 5.6.2.1 Germany
      • 5.6.2.2 United Kingdom
      • 5.6.2.3 France
      • 5.6.2.4 Italy
      • 5.6.2.5 Spain
      • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia-Pacific
      • 5.6.3.1 China
      • 5.6.3.2 Japan
      • 5.6.3.3 India
      • 5.6.3.4 Australia
      • 5.6.3.5 South Korea
      • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East
      • 5.6.4.1 GCC
      • 5.6.4.2 South Africa
      • 5.6.4.3 Rest of Middle East
    • 5.6.5 South America
      • 5.6.5.1 Brazil
      • 5.6.5.2 Argentina
      • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abcam PLC
    • 6.1.2 AMSBIO
    • 6.1.3 Biovision Inc
    • 6.1.4 Cell Biolabs, Inc
    • 6.1.5 Enzo life sciences, Inc
    • 6.1.6 Merck KGaA
    • 6.1.7 ImmunoChemistry Technologies
    • 6.1.8 Promega Corporation
    • 6.1.9 Qiagen
    • 6.1.10 Thermo fisher scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS